Compare ORA & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORA | DVA |
|---|---|---|
| Founded | 1965 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Misc Health and Biotechnology Services |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 8.2B |
| IPO Year | 2004 | 1995 |
| Metric | ORA | DVA |
|---|---|---|
| Price | $113.00 | $114.57 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 4 |
| Target Price | $117.13 | ★ $145.00 |
| AVG Volume (30 Days) | 583.1K | ★ 709.9K |
| Earning Date | 11-03-2025 | 02-12-2026 |
| Dividend Yield | ★ 0.43% | N/A |
| EPS Growth | ★ 11.26 | 5.63 |
| EPS | 2.18 | ★ 9.76 |
| Revenue | $944,248,000.00 | ★ $13,317,965,000.00 |
| Revenue This Year | $11.57 | $6.50 |
| Revenue Next Year | $17.28 | $2.97 |
| P/E Ratio | $50.70 | ★ $11.63 |
| Revenue Growth | ★ 6.07 | 5.14 |
| 52 Week Low | $61.58 | $112.54 |
| 52 Week High | $116.66 | $179.60 |
| Indicator | ORA | DVA |
|---|---|---|
| Relative Strength Index (RSI) | 54.31 | 40.27 |
| Support Level | $110.13 | $112.54 |
| Resistance Level | $113.48 | $114.34 |
| Average True Range (ATR) | 2.31 | 2.07 |
| MACD | -0.16 | -0.15 |
| Stochastic Oscillator | 71.61 | 19.47 |
Ormat Technologies Inc is engaged in the geothermal and recovered energy power business. It is engaged in three business segments: Electricity Segment. where the company develops, builds, owns and operates geothermal, solar PV and recovered energy-based power plants in the United States and geothermal power plants in other countries and sell the electricity generated. Product Segment includes designing, manufacturing and selling equipment for geothermal and recovered energy-based electricity generation and providing services relating to the engineering, procurement and construction of geothermal and recovered energy-based power plants. Energy Storage Segment includes owning and operating grid-connected which provide capacity, energy and ancillary services directly to the electric grid.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.